Non-Opioid pain pump put to the test after colon surgery
NCT ID NCT07821307
First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time
Summary
Researchers are testing an experimental drug called opiranserin (VVZ-149) to see if it eases pain after laparoscopic colon surgery. The trial enrolls 66 adults scheduled for this operation. Participants receive the drug through a patient-controlled pump or a placebo, and researchers track pain levels and how much pain medication each person uses over 12 hours.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- opiranserin (VVZ-149), an experimental non-opioid pain drug given through a patient-controlled pump
- What this could lead to
- If it works, opiranserin could offer a non-opioid option for controlling pain after surgery, giving patients an alternative to drugs like morphine.
- What could go wrong
- This is a small phase 2 trial of 66 people, so any pain relief seen may not hold up in larger studies. Opiranserin may not beat standard pain control, and it could cause side effects that outweigh its benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
66 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects must have the ability to voluntarily provide written informed consent, understand study * Men and women subjects aged ≥19 years and \<75 years * Female subjects who are not pregnant or breastfeeding * Subjects must be undergoing a planned first laparoscopic colectomy * Subjects classified in American Society Anesthesiologist (ASA) risk class of I or II Exclusion Criteria: * Subjects undergoing emergency or unplanned surgery * Subjects who had a previous laparoscopic colectomy or resection procedure * Subjects with pre-existing conditions causing preoperative pain around the site of surgery * Female subjects who are pregnant or breastfeeding * Diagnosis of chronic pain (e.g., persistent pain with the intensity of NRS ≥ 5 at baseline)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain, postoperative / acute pain are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
Seoul, South Korea